XTL Biopharmaceuticals Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $8.6M
Liabilities Breakdown FY2024
Total Liabilities: $3.1M
Asset Breakdown
Total Assets: $8.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $371.0K | 4.3% |
| Accounts Receivable | $138.0K | 1.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $3.2M | 37.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.8M | 56.7% |
Liabilities Breakdown
Total Liabilities: $3.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $196.0K | 6.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.9M | 93.7% |